Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488470 · ClinicalTrials.gov registry record
QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 22
- Enrollment target
NCT05488470 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 22 participants.
The verdict
NCT05488470 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The LINQ QT Study is a prospective, non-randomized, multi-center, observational, post-market clinical study investigating QT interval changes due to antiarrhythmic drug loading.
Interventions
- DEVICE LINQ/LINQ II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05488470
The ClinicalTrials.gov registry entry for NCT05488470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LINQ/LINQ II is the first listed.
NCT05488470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05488470 about?
NCT05488470 is a clinical study titled "QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)". The LINQ QT Study is a prospective, non-randomized, multi-center, observational, post-market clinical study investigating QT interval changes due to antiarrhythmic drug loading.
What is the current status of trial NCT05488470?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2023-02-20. Estimated completion is 2024-07-23.
What interventions are being tested in trial NCT05488470?
The interventions under investigation include: LINQ/LINQ II (DEVICE).
Who is sponsoring clinical trial NCT05488470?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.